News and Events
LakePharma and NJ Bio Form Strategic Alliance to Provide Streamlined Antibody-Drug Conjugate ServicesAdded on 2020-02-11
LakePharma will manufacture and provide antibodies as starting materials for ADC development carried out by NJ Bio in a single, seamless workflow for clients, making therapeutic ADC manufacturing from initial antibody discovery to the production of the drug conjugates significantly more efficient both in time and expense.
LakePharma Announces Expansion into the Dallas/Fort Worth MetroplexAdded on 2019-07-23
LakePharma has opened a new office in Dallas, Texas. The new location allows LakePharma to better align its services with clients’ demands in the rapidly growing biologics industry.
LakePharma Launches GMP Manufacturing of Recombinant Proteins and Antibodies in the Bay AreaAdded on 2019-04-02
LakePharma Announces Dedicated Vector Center to Support Gene and Cell TherapyAdded on 2019-02-26
LakePharma Announces its GMP Biorepository Facility near Boston is Now Operational, Plans Additional HiringAdded on 2019-01-15